Cardinal Health extends CVS deal. What it means for Cardinal Health stock
Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash
Cardinal Health has extended its pharmaceutical distribution agreement with CVS Health through June 30, 2032. The company also reaffirmed its fiscal year 2027 non-GAAP earnings per share guidance, projecting 13% to 15% growth. The Cardinal Health stock traded flat at EUR 202.90 in weekend trading after the announcement.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.